These findings are consistent with human and mouse studies showing that although loss of the second allele can accelerate tumor progression, mutation of a single LKB1 allele is by itself tumorigenic (i.e. LKB1 can be haploinsufficient) [9], [17]. Here, STK11 is linked to neoplasm.